From the Globe and Mail:
Drug makers unlikely to embrace new proposal
A proposal for a national pharmacare program will not win immediate endorsement from drug companies, a leading health expert says.

Michael Dector, chairman of the newly formed Health Council of Canada, said a national prescription drug program could limit points of access for Canadian pharmaceutical companies to have their drugs approved and funded.